当前位置: 首页 > 期刊 > 《医药产业资讯》 > 20209
编号:13494657
姜黄素通过活化SIRT1拮抗CCl4诱导的小鼠肝脏纤维化(5)
http://www.100md.com 2020年3月25日 《中国医药导报》 20209
     [16] Mccubrey JA,Lertpiriyapong K,Steelman LS,et al. Effects of resveratrol,curcumin,berberine and other nutraceuticals on aging,cancer development,cancer stem cells and microRNAs [J]. Aging,2017,9(6):1477-1536.

    [17] Lee DE,Lee SJ,Kim SJ,et al. Curcumin Ameliorates Nonalcoholic Fatty Liver Disease through Inhibition of O-GlcNAcylation [J]. Nutrients,2019,11(11):E2702.

    [18] Ding RB,Bao J,Deng CX. Emerging roles of SIRT1 in fatty liver diseases [J]. Int J Biol Sci,2017,13(7):852-867.

    [19] Yin H,Hu M,Liang X,et al. Deletion of SIRT1 From Hepatocytes in Mice Disrupts Lipin-1 Signaling and Aggravates Alcoholic Fatty Liver [J]. Gastroenterol,2014, 146(3):801-811.

    [20] Marengo A,Rosso C,Bugianesi E. Liver Cancer:Connections with Obesity,Fatty Liver,and Cirrhosis [J]. Annu Rev Med,2016,67:103-117.

    [21] Unalp-Arida A,Ruhl CE. PNPLA3 I148M and liver fat and fibrosis scores predict liver disease mortality in the United States population [J]. Hepatology,2019,31032.

    (收稿日期:2019-09-30 本文編辑:封 华), 百拇医药(申昌军 张帅 李浩鹏)
上一页1 2 3 4 5